Literature DB >> 34149224

Afibrinogenemia Diagnosed During Pregnancy Successfully Managed with Targeted Cryoprecipitate Transfusion: A Case Report.

Athulya Shajan1, Neetha George1, Sareena Gilvaz1, Siju V Abraham2.   

Abstract

BACKGROUND: We report a case of afibrinogenemia in a lady, which was detected for the first time during her pregnancy. CASE: A 24-year-old G4A3 was referred as a case of vaginal bleeding, after a cervical cerclage at 14 weeks of gestation. Elastometry targeted correction of coagulopathy was done initially, and targeted cryoprecipitate transfusion was done to maintain her gestation. She underwent induced vaginal delivery at 34 weeks of gestation. Fourteen days postpartum, the mother and child were discharged home well.
CONCLUSION: Coagulation factor deficiency should be considered as a rare cause for RPL. Serum fibrinogen level of 50-100 mg/dl during pregnancy seems to be a safe and adequate target to maintain in pregnant patients with afibrinogenemia. © Federation of Obstetric & Gynecological Societies of India 2020.

Entities:  

Keywords:  Afibrinogenemia; Cryoprecipitate; Fibrinogen; Pregnancy; Rotational thromboelastometry; Viscoelastometry

Year:  2020        PMID: 34149224      PMCID: PMC8166989          DOI: 10.1007/s13224-020-01389-3

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  24 in total

Review 1.  Coagulation factor deficiencies and pregnancy loss.

Authors:  Aida Inbal; Laszlo Muszbek
Journal:  Semin Thromb Hemost       Date:  2003-04       Impact factor: 4.180

Review 2.  The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  P H B Bolton-Maggs; D J Perry; E A Chalmers; L A Parapia; J T Wilde; M D Williams; P W Collins; S Kitchen; G Dolan; A D Mumford
Journal:  Haemophilia       Date:  2004-09       Impact factor: 4.287

Review 3.  Congenital afibrinogenaemia in pregnancy.

Authors:  P K Mensah; C Oppenheimer; C Watson; S Pavord
Journal:  Haemophilia       Date:  2011-01       Impact factor: 4.287

4.  Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.

Authors:  C K Okerberg; L A Williams; M L Kilgore; C H Kim; M B Marques; J Schwartz; H P Pham
Journal:  Vox Sang       Date:  2016-06-01       Impact factor: 2.144

Review 5.  Diagnosis of congenital fibrinogen disorders.

Authors:  Aurélien Lebreton; Alessandro Casini
Journal:  Ann Biol Clin (Paris)       Date:  2016-08-01       Impact factor: 0.459

Review 6.  Congenital fibrinogen disorders: an update.

Authors:  Philippe de Moerloose; Alessandro Casini; Marguerite Neerman-Arbez
Journal:  Semin Thromb Hemost       Date:  2013-07-12       Impact factor: 4.180

7.  Congenital afibrinogenemia with successful delivery.

Authors:  T Kobayashi; T Asahina; K Maehara; M Itoh; N Kanayama; T Terao
Journal:  Gynecol Obstet Invest       Date:  1996       Impact factor: 2.031

8.  ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2002-08       Impact factor: 3.561

9.  Congenital hypofibrinogenemia in pregnancy: a report of 11 cases.

Authors:  He Cai; Meiying Liang; Jingjing Yang; Xiaohui Zhang
Journal:  Blood Coagul Fibrinolysis       Date:  2018-03       Impact factor: 1.276

Review 10.  Cryoprecipitate therapy.

Authors:  B Nascimento; L T Goodnough; J H Levy
Journal:  Br J Anaesth       Date:  2014-06-27       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.